The WHO Executive Board will discuss global health priorities this week, including substandard and falsified medical products, with key implications for public pharmaceutical initiatives ...
Washington was the biggest contributor to the Geneva-based organization, which Trump claimed had 'ripped us off', and the US withdrawal could leave global health initiatives short of funding.